CoChat

Intravital FLIM-FRET Imaging Reveals Dasatinib-Induced Spatial Control of Src in Pancreatic Cancer

Nobis, Max, McGhee, Ewan J., Morton, Jennifer P., Schwarz, Juliane P., Karim, Saadia A., Quinn, Jean, Edward, Mike, Campbell, Andrew D., McGarry, Lynn C., Evans, T.R. Jeffry, Brunton, Valerie G., Frame, Margaret C., Carragher, Neil O., Wang, Yingxiao, Sansom, Owen J., Timpson, Paul, Anderson, Kurt I. · 2013 · Cancer Research
Cited by 143

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Cancer invasion and metastasis occur in a complex three-dimensional (3D) environment, with reciprocal feedback from the surrounding host tissue and vasculature-governing behavior. In this study, we used a novel intravital method that revealed spatiotemporal regulation of Src activity in response to the anti-invasive Src inhibitor dasatinib. A fluorescence lifetime imaging microscopy–fluorescence resonance energy transfer (FLIM-FRET) Src biosensor was used to monitor drug-targeting efficacy in a transgenic p53-mutant mouse model of pancreatic cancer. In contrast to conventional techniques, FLIM-FRET analysis allowed for accurate, time-dependent, live monitoring of drug efficacy and clearance in live tumors. In 3D organotypic cultures, we showed that a spatially distinct gradient of Src activity exists within invading tumor cells, governed by the depth of penetration into complex matrices. In parallel, this gradient was also found to exist within live tumors, where Src activity is enhanced at the invasive border relative to the tumor cortex. Upon treatment with dasatinib, we observed a switch in activity at the invasive borders, correlating with impaired metastatic capacity in vivo. Src regulation was governed by the proximity of cells to the host vasculature, as cells distal to the vasculature were regulated differentially in response to drug treatment compared with cells proximal to the vasculature. Overall, our results in live tumors revealed that a threshold of drug penetrance exists in vivo and that this can be used to map areas of poor drug-targeting efficiency within specific tumor microenvironments. We propose that using FLIM-FRET in this capacity could provide a useful preclinical tool in animal models before clinical translation. Cancer Res; 73(15); 4674–86. ©2013 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-12-4545

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 143

Metadata

Authors
Nobis, M., McGhee, E. J., Morton, J. P., Schwarz, J. P., Karim, S. A., Quinn, J., Edward, M., Campbell, A. D., McGarry, L. C., Evans, T. R. J., Brunton, V. G., Frame, M. C., Carragher, N. O., Wang, Y., Sansom, O. J., Timpson, P., & Anderson, K. I.
Venue
Cancer Research
Published
2013-07-31
Volume
73
Issue
15
Pages
4674-4686
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2162666026
Cited by
143
References
8
FWCI
14.05
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Intravital FLIM-FRET Imaging Reveals Dasatinib-Induced Spatial Control of Src in Pancreatic Cancer. https://app.cochat.ai/papers/10.1158/0008-5472.can-12-4545
The paper
Nobis, M., McGhee, E. J., Morton, J. P., Schwarz, J. P., Karim, S. A., Quinn, J., Edward, M., Campbell, A. D., McGarry, L. C., Evans, T. R. J., Brunton, V. G., Frame, M. C., Carragher, N. O., Wang, Y., Sansom, O. J., Timpson, P., & Anderson, K. I. (2013). Intravital FLIM-FRET Imaging Reveals Dasatinib-Induced Spatial Control of Src in Pancreatic Cancer. Cancer Research. https://doi.org/10.1158/0008-5472.can-12-4545

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.